These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6616245)

  • 21. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphetamine exerts anomalous effects on dopaminergic neurons in neonatal rats in vivo.
    Trent F; Nakamura S; Tepper JM
    Eur J Pharmacol; 1991 Nov; 204(3):265-72. PubMed ID: 1773829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of dopamine-containing substantia nigra neurons in freely moving cats.
    Trulson ME
    Neurosci Biobehav Rev; 1985; 9(2):283-97. PubMed ID: 3925396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
    Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
    Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nigral reticulata neurons: potentiation of responsiveness to amphetamine with long-term treatment.
    Kamata K; Rebec GV
    Brain Res; 1985 Apr; 332(1):188-93. PubMed ID: 3995264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apomorphine-induced inhibition of substantia nigra dopamine neurons: effects of unilateral injection through the internal carotid artery.
    Akaoka H; Vitte PA; Lestage P; Saunier CF; Bobillier P; Chouvet G
    Neurosci Lett; 1989 Mar; 98(2):205-10. PubMed ID: 2710414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
    Jackson DM; Walters JR; Miller LP
    Brain Res; 1982 Nov; 250(2):271-82. PubMed ID: 6129029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
    Cox RF; Neumeyer JL; Waszczak BL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):355-62. PubMed ID: 3171980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area.
    Kamata K; Rebec GV
    Life Sci; 1984 Jun; 34(24):2419-27. PubMed ID: 6727576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium attenuates the development of lesion-induced behavioral supersensitivity to apomorphine.
    Gruenthal M
    Brain Res; 1984 Jul; 306(1-2):189-96. PubMed ID: 6432217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphetamine-induced increases in dopaminergic single cell firing rate after haloperidol pretreatment. Correlation with extrapyramidal side effects.
    Welch JJ; Kim HS; Liebman J
    Neuropharmacology; 1980 Apr; 19(4):371-7. PubMed ID: 7383282
    [No Abstract]   [Full Text] [Related]  

  • 34. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(1):30-7. PubMed ID: 2919369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of effects of dopaminergic agonists on neuronal activity in the caudate-putamen of the rat following long-term d-amphetamine administration.
    Rebec GV; Groves PM
    Pharmacol Biochem Behav; 1976 Sep; 5(3):349-57. PubMed ID: 996066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock.
    Creese I; Kuczenski R; Segal D
    Pharmacol Biochem Behav; 1982 Aug; 17(2):375-6. PubMed ID: 6291070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of gamma-butyrolactone on behavior due to dopaminergic drugs.
    Dougherty GG; Ellinwood EH
    Physiol Behav; 1983 Apr; 30(4):607-12. PubMed ID: 6683846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons.
    Heidenreich BA; Rebec GV
    Synapse; 2000 Oct; 38(1):80-6. PubMed ID: 10941143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.